VKH
OCRX

Virtu KCG Holdings’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Virtu KCG Holdings’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$248K Buy
213,531
+141,040
+195% +$164K 0.01% 1916
2017
Q1 		$95K Buy
72,491
+29,446
+68% +$37.5K ﹤0.01% 2699
2016
Q4 		$90K Buy
+43,045
New +$100K ﹤0.01% 2953
2016
Q2 		– Sell
-13,382
Closed -$39K – 3568
2016
Q1 		$39K Buy
+13,382
New +$38.2K ﹤0.01% 2511

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's OCRX Position: Q2 2017 in Review

Virtu KCG Holdings increased its Ocera Therapeutics, Inc. (OCRX) stake by 195% in Q2 2017, buying an estimated $164K and bringing the position to 213,531 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #1916.

Virtu KCG Holdings first reported a position in OCRX in Q1 2016 and has held it in 4 quarters since. 24 funds tracked by Wall St. Rank hold OCRX as of Q2 2017.

  • Virtu KCG Holdings held 213,531 shares of Ocera Therapeutics, Inc. worth $248K as of Q2 2017.
  • Virtu KCG Holdings bought 141,040 Ocera Therapeutics, Inc. shares in Q2 2017, an estimated $164K.
  • Ocera Therapeutics, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1916 holding.
  • Virtu KCG Holdings first reported a position in Ocera Therapeutics, Inc. in Q1 2016 and has held it in 4 quarters since.
  • 24 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.